Drug intelligence / Profile preview

Caranbax-UTI

Development stage
Unknown
Lead developer
Medicox Lifescience
Modality
Small Molecules
Administration
Oral
01

Overview

Caranbax-UTI is an oral branded generic combination product marketed by Medicox Lifescience for the management and prophylaxis of urinary tract infections (UTIs). The formulation typically consists of Cranberry extract, D-Mannose, and Potassium Magnesium Citrate. D-Mannose and Cranberry-derived proanthocyanidins work synergistically to prevent the adhesion of pathogenic bacteria, particularly *Escherichia coli*, to the uroepithelial cells of the bladder wall, thereby facilitating their clearance through urination. Potassium Magnesium Citrate serves as a systemic and urinary alkalizer, increasing the pH of the urine to alleviate the burning sensation (dysuria) and discomfort associated with UTIs while creating an environment less favorable for bacterial proliferation.

Brand names
Caranbax-UTI
Other names
Cranberry extract + D-Mannose + Potassium Magnesium Citrate
02

Targets

FimH (Type 1 fimbrial adhesin)PapG (PapG adhesin)

Beyond the preview

Go deeper on Caranbax-UTI.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caranbax-UTI.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call